A Trial of Alemtuzumab Adjunctive Therapy in Allogeneic Hematopoietic Cell Transplantation with Minimal Conditioning for Severe Combined Immunodeficiency

類似資料

• A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency
  著者:: Dvorak, Christopher C., 等
  出版事項: (2014)
• Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: Need for safer conditioning and reduced late effects
  著者:: Horn, Biljana, 等
  出版事項: (2013)
• Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency
  著者:: Wahlstrom, Justin T., 等
  出版事項: (2015)
• Allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency
  著者:: Morris, Emma C.
  出版事項: (2020)
• Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation
  著者:: van Besien, Koen, 等
  出版事項: (2011)